perillaldehyde has been researched along with Neoplasm Metastasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Kobayashi, Y; Lin, Z; LingHu, X; Nagai, A; Wa, Q; Wang, B; Wang, Y; Xie, S; Xu, X; Yu, A; Zhong, S | 1 |
1 other study(ies) available for perillaldehyde and Neoplasm Metastasis
| Article | Year |
|---|---|
Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines.
Topics: Animals; Bone Neoplasms; Humans; Male; Mice; Monoterpenes; Neoplasm Metastasis; Neoplasm Proteins; Osteoclasts; PC-3 Cells; Prostatic Neoplasms; RANK Ligand; RAW 264.7 Cells; Signal Transduction | 2022 |